Volatile anesthetics

Wylie and Churchill-Davidsons: A Practice of Anesthesia, Seventh Edition

Volumn , Issue , 2003, Pages 523-542

  O'Keeffe, Niall ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44449132450     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (213)

1. Jones RM. Desflurane and sevoflurane: inhalation anaesthetics for this decade. Br J Anaesth 1990; 65: 527-36.
2. Johnstone M. The human cardiovascular response to Fluothane anaesthesia. Br J Anaesth 1956; 28: 392-6.
3. Seiflow GHF. The non-inflammability of Fluothane. Br J Anaesth 1957; 29: 438.
4. Targ AG, Yasuda N, Eger EI II. Solubility of I-653, sevoflurane, isoflurane, and halothane in plastics and rubber composing a conventional anesthetic circuit. Anesth Analg 1989; 69: 218-25.
5. Merkel G, Eger EI II. A comparative study of halothane and halopro-pane anesthesia. Including method for determining equipotency. Anesthesiology 1963; 24: 346-57.
6. Saidman LJ, Eger EI 2nd. Effect of nitrous oxide and narcotic premedication on the alveolar concentration of halothane required for anesthesia. Anesthesiology 1964; 25: 302-6.
7. Gregory GA, Eger EI 2nd, Munson ES. The relationship between age and halothane requirements in man. Anesthesiology 1969; 30: 488-91.
8. Steffey EP, Eger EI II. Hyperthermia and halothane MAC in the dog. Anesthesiology 1974; 14: 392-6.
9. Quasha AL, Eger EI II, Tinker JH. Determination and applications of MAC. Anesthesiology 1980; 53: 315-34.
10. Lerman J, Gregory GA, Willis MM, Eger EI Age and solubility of volatile anesthetics in blood. Anesthesiology 1984; 61:139-43.
11. Yasuda N, Lockhart SH, Eger EI, et al. Kinetics of desflurane, isoflurane and halothane in humans. Anesthesiology 1991; 74: 489-98.
12. Carpenter RL, Eger EI 2nd, Johnson BH, et al. The extent of metabolism of inhaled anesthetics in humans. Anesthesiology 1986; 65: 201-5.
13. Frost EAM. Inhalational anaesthetic agents in neurosurgery. Br J Anaesth 1984;56:47S-56S.
14. Miletich DJ, Ivankovich AD, Albrecht RF, et al. Absence of autoregula-tion of cerebral blood flow during halothane and enflurane anesthesia. Anesth Analg 1976 55:100-6.
15. Artru AA. Effects of halothane and fentanyl on the rate of CSF production in dogs. Anesth Analg 1983; 62: 581-5.
16. Adams RW, Gronert GA, Sundt TM, Michenfelder JD. Halothane, hypo-capnia and cerebrospinal fluid pressure in neurosurgery. Anesthesiology 1972; 37: 510-57.
17. Misfeldt BB, Jorgensen PB, Rishoj M. The effect of nitrous oxide and halothane upon the intracranial pressure in hypocapnic patients with intracranial disorders. Br J Anaesth 1974; 46: 853-8.
18. Stullken EH, Milde JH, Michenfelder JD, Tinker JH. The nonlinear responses of cerebral metabolism to low concentrations of halothane, enflurane, isoflurane and thiopental. Anesthesiology 1977; 46: 28-34.
19. Modica PA, Tempelhoff R, White PF. Pro- and anticonvulsant effects of anaesthetics (Part 1). Anesth Analg 1990; 70: 303-15.
20. Uhl RR, Squires KC, Bruce DL, Starr A. Effect of halothane anaesthesia on the human cortical visual evoked response. Anesthesiology 1980; 53: 273-6.
21. Thornton C, Heneghan CPH, James MFM, Jones JG. Effects of halothane or enflurane with controlled ventilation on auditory evoked potentials. Br J Anaesth 1984; 56: 315-23.
22. Inomata S, Yamashita S, Toyooka H, et al. Anaesthetic induction time for tracheal intubation using sevoflurane or halothane in children. Anaesthesia 1998; 53: 440-5.
23. Black GW. A review of the pharmacology of halothane. Br J Anaesth 1965; 37: 688-705.
24. Knill RL, Gelb AW. Ventilatory responses to hypoxia and hypercapnia during halothane sedation and anaesthesia in man. Anesthesiology 1978;49:244-51.
25. Dahan A, Teppema L. Influence of low-dose anaesthetic agents on ventilatory control: where do we stand? Br J Anaesth 1999; 83:199-201.
26. Tokics L, Hedenstierna G, Strandberg A, Brismar B, Lundquist H. Lung collapse and gas exchange during general anesthesia: effects of spontaneous breathing, muscle paralysis, and positive end-expiratory pressure. Anesthesiology 1987; 66:157-67.
27. Rogers DN, Benumof JL. Halothane and isoflurane do not decrease Pa02 during one-lung ventilation in intravenously anesthetised patients. Anesth Analg 1985; 64: 946-54.
28. Johnson D, Mayers I. The effects of halothane in hypoxic pulmonary vasoconstriction. Anesthesiology 1990; 72:125-33.
29. Hirshman CA, Edelstein G, Peetz S, et al. Mechanism of action of inhalational anesthesia on airways. Anesthesiology 1982; 56:107-11.
30. Katoh T, Ikeda K. A comparison of sevoffurane with halothane, enfiurane and isoflurane on bronchoconstriction caused by histamine. Can J Anesth 1994; 41:1214-19.
31. Roizen MF, Stevens WC. Multiform ventricular tachycardia due to the interaction of aminophylline and halothane. Anesth Analg 1978; 57: 738-41.
32. Epstein RM, Deutsch S, Cooperman LH, et al. Splanchnic circulation during halothane anesthesia in normal man. Anesthesiology 1966; 27: 654-61.
33. Deutsch S, Goldberg M, Stephen GW, Wu WH. Effects of halothane anesthesia on renal function in normal man. Anesthesiology 1966; 27: 793-804.
34. Gelman S, Fowler KC, Smith LR. Regional blood flow during isoflurane and halothane anaesthesia. Anesth Analg 1984; 63: 557-65.
35. Hickey RF, Sybert SE, Verrier ED, Casong BA. Effects of halothane, enfiurane, and isoflurane on coronary blood flow autoregulation and coronary vascular reserve in the canine heart. Anesthesiology 1988; 68: 21-30.
36. Eger EI II, Smith NT, Stoelting RK, et al. Cardiovascular effects of halothane in man. Anesthesiology 1970; 32: 396-409.
37. Rusy BF, Komai H. Anesthetic depression of myocardial contractility: a review of possible mechanisms. Anesthesiology 1987; 67: 45-66.
38. Housmans PR, Murat I. Comparative effects of halothane, enfiurane and isoflurane at equipotent anesthetic concentrations on isolated ventricular myocardium of the ferret. Anesthesiology 1988; 69:451-63.
39. Atlee JL, Bosjnak ZJ. Mechanisms for cardiac dysrhythmias during anesthesia. Anesthesiology 1990; 72: 347-74.
40. Duke PC, Fownes D, Wade JG. Halothane depresses baroreflex control of heart rate in man. Anesthesiology 1977; 46:184-7.
41. Merlos JR, Bosnjak ZJ, Purtock RV, et al. Halothane and enfiurane effects on SA node cells. Anesthesiology 1980; 53: S143.
42. Atlee JL III, Peterson ML. Halothane, isoflurane, enfiurane and A-V conduction: awake vs. anesthesia. Anesthesiology 1982; 57:A15.
43. Katz RL, Katz GJ. Surgical infiltration of pressor drugs and their interaction with volatile anaesthetics. Br J Anaesth 1966; 38:712-718.
44. Black GW, Linde HW, Dripps RD, Price HL Circulatory changes accompanying respiratory acidosis during halothane (Fluothane) anaesthesia in man. Br J Anaesth 1959; 31: 238-46.
45. Johnston RR, Eger EI, Wilson C. A comparative interaction of epinephrine with enfiurane, isoflurane and halothane in man. Anesth Analg 1976; 55: 709-12.
46. Willatts DG, Harrison AR, Groom JF, Crowther A. Cardiac arrhythmias during outpatient dental anaesthesia: comparison of halothane with enfiurane. Br J Anaesth 1983; 55: 399-403.
47. Hutchison GL, Davies CA, Main G, Gray IG. Incidence of arrhythmias in dental anaesthesia: a crossover comparison of halothane and isoflurane. Br J Anaesth 1989; 62: 518-521.
48. Kapur PA, Bloor BC, Flacke WE, Olewine SK. Comparison of cardiovascular responses to verapamil during enfiurane, isoflurane, or halothane anesthesia in the dog. Anesthesiology 1984; 61:156-60.
49. Maze M, Mason DM, Kates K. Verapamil decreases MAC for halothane in dogs. Anesthesiology 1983; 59: 327-9.
50. Durand PG, Lehot JJ, Foex P. Calcium-channel blockers and anaesthesia. Can J Anesth 1991; 38: 75-89.
51. Ross S, Foex P. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999; 82: 622-32.
52. Gissen AJ, Karis JH, Nastuk WL. Effect of halothane on neuromuscular transmission. JAMA 1966; 197: 116-20.
53. Saitoh Y, Toyooka H, Amaha K. Recoveries of post-tetanic twitch and train-of-four responses after administration of vecuronium with different inhalation anaesthetics and neurolept-anaesthesia. Brit J Anaesth 1993; 70: 402-4.
54. Jones RM. Clinical comparison of inhalation anaesthetic agents. Br J Anaesth 1984; 56: 57S-60S.
55. 2 during recovery from anaesthesia. Br J Anaesth 1968; 40: 398-407.
56. Soliman MG, Gillies DMM. Muscular hyperactivity after general anaesthesia. Can Anesth SocJ 1972; 19: 529-35.
57. Sessler DI, Olofsson CI, Rubinstein EH, Beebe JJ. The thermoregulatory threshold in humans during halothane anesthesia. Anesthesiology 1988; 68: 836-42.
58. Sessler DI, Rubinstein EH, Moayeri A. Physiologic response to mild peri-anesthetic hypothermia in humans. Anesthesiology 1991; 75: 594-610.
59. Macintyre PE, Pavlin EG, Dwersteg JF. Effect of meperidine on oxygen consumption, carbon dioxide production and respiratory gas exchange in post-anesthesia shivering. Anesth Analg 1987; 66: 751-5.
60. Fee JPH, Thompson GH. Comparative tolerability profiles of the inhaled anaesthetics. Drug Safety 1997; 16:157-70.
61. Ray DC, Drummond GB. Halothane hepatitis. Br J Anaesth 1991; 67: 84-99.
62. El Mikatti N, Healy TEJ. Hepatic injury associated with halogenated anaesthetics: cross sensitisation and its clinical implications. Eur J Anaesth 1997; 14: 7-14.
63. Njoku D, Laster MJ, Gong DH, et al. Biotransformation of halothane, enfiurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 1997; 84: 173-8.
64. Adams AP. Enfiurane in clinical practice. Br J Anaesth 1981; 53: 27S-41S.
65. Mazze RI, Woodruff RE, Heerdt ME. Isoniazid-induced enfiurane defluorination in humans. Anesthesiology 1982; 57: 5-8.
66. Persson A, Peterson E, Wahlin A. EEG changes during general anaesthesia with enfiurane (Efrane) in comparison with ether. Acta Anaesthesiol Stand 1978; 22: 339-48.
67. Eintrei C, Leszniewski W, Carisson C. Local application of 133Xenon for measurement of regional cerebral blood flow (rCBF) during halothane, enfiurane, and isoflurane anesthesia in humans. Anesthesiology 1985; 63: 391-4.
68. Eger EI II. Isoflurane: a review. Anesthesiology 1981; 55: 559-76.
69. Wren WS, Allen P, Synnott A, et al. Effects of halothane, isoflurane and enfiurane on ventilation in children. Br J Anaesth 1987; 59: 399-409.
70. Knill RL, Manninen PH, Clement L. Ventilation and chemoreflexes during enfiurane sedation and anaesthesia in man. Can Anesth SocJ 1979; 26: 353-60.
71. Calverley RK, Smith NT, Jones CW, et al. Ventilatory and cardiovascular effects of enfiurane anaesthesia during spontaneous ventilation in man. Anesth Analg 1978; 57: 610-18.
72. Hirshman CA, Bergman NA. Halothane and enfiurane protect against bronchospasm in an asthma dog model. Anesth Analg 1978; 57: 619-28.
73. Katoh T, Ikeda K. A comparison of sevoflurane with halothane, enfiurane and isoflurane on bronchoconstriction caused by histamine. Can J Anesth 1994; 41: 1214-19.
74. Marshall C, Lindgren L, Marshall BE. Effects of halothane, enfiurane, and isoflurane on hypoxic pulmonary vasoconstriction in rat lungs in vitro. Anesthesiology 1984; 60: 304-8.
75. Rees Dl, Gaines GY. One-lung anaesthesia - a comparison of pulmonary gas exchange during anaesthesia with ketamine or enfiurane. Anesth Analg 1984; 63: 521-5.
76. Zimpfer M, Gilly H, Krosl P, et al. Importance of myocardial loading conditions in determining the effects of enfiurane on left ventricular function in the intact and isolated canine heart. Anesthesiology 1983; 58:159-69.
77. Black GW. Enfiurane. Br J Anaesth 1979; 51: 627-39.
78. Calverley RK, Smith NT, Prys-Roberts C, et al. Cardiovascular effects of enfiurane anesthesia during controlled ventilation in man. Anesth Analg 1978; 57: 619-28.
79. Rupp SM, Miller RD, Gencarelli PJ. Vecuronium-induced neuromuscular blockade during enfiurane, isoflurane, and halothane anesthesia in humans. Anesthesiology 1984; 60:102-5.
80. Withington DE, Donati F, Bevan DR, Varin F. Potentiation of atracurium neuromuscular blockade by enfiurane: time-course of effect. Anesth Analg 1991 72:469-73.
81. Cousins MJ, Mazze RI. Methoxyflurane toxicity: a study of dose response in man. JAMA 1973; 225:1611-16.
82. Kharasch ED, Hankins DC, Thummel KE. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane toxicity. Anesthesiology 1995; 82: 689-99.
83. Fang ZX, Eger EI II, Laster MJ, et al. Carbon monoxide production from degradation of desflurane, enfiurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme. Anesth Analg 1995; 80:1187-93.
84. Neumann MA, Laster MJ, Weiskopf RB, et al. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption. Anesth Analg 1999;89:768-73.
85. Corbett TH. Cancer and congenital anomalies associated with anesthetics. Ann NY AcadSci 1976; 271: 58-66.
86. Eger EI II, White AE, Brown CL, et al. A test of the carcinogenicity of enfiurane, isoflurane, halothane, methoxyflurane, and nitrous oxide in mice. Anesth Analg 1978; 57:678-694.
87. Wade JG, Stevens WC. Isoflurane: an anesthetic for the eighties. Anesth Analg 1981; 6: 666-82.
88. Eger EI II. The pharmacology of isoflurane. Br J Anaesth 1984; 56: 71S-99S.
89. Stevens WC, Dolan WM, Gibbons RT, et al. Minimum alveolar concentrations (MAC) of isoflurane with and without nitrous oxide in patients of various ages. Anesthesiology 1975; 42: 197-200.
90. Cameron CB, Robinson S, Gregory GA. The minimum anesthetic concentration of isoflurane in children. Anesth Analg 1984; 63: 418-40.
91. Vitez TS, White PF, Eger EI II. Effects of hypothermia on halothane MAC and isoflurane MAC in the rat. Anesthesiology 1974; 41: 80-1.
92. Cromwell TH, Eger EI II, Stevens WC, Dolan WM. Forane uptake, excretion, and blood solubility in man. Anesthesiology 1971; 35: 401-8.
93. Munson ES, Eger EI II, Tham MK, Embro WJ. Increase in anesthetic uptake, excretion, and blood solubility in man after eating. Anesth Analg 1978;57:224-31.
94. Yasuda N, Lockhardt SH, Eger EI. Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 1991; 72: 316-24.
95. Holaday DA, Fiserova-Bergerova V, Latto IP, Zumbiel MA. Resistance of isoflurane to biotransformation in man. Anesthesiology 1975; 43: 325-32.
96. Adam N. Effects of general anesthetics on memory functions in man.y Comp Physiol Psychol 1973; 83: 294-305.
97. Eger EI II, Stevens WC, Cromwell TH. The electroencephalogram in man anesthetized with Forane. Anesthesiology 1971 35: 504-8.
98. Manninen PH, Nicholas JF, Lam AM. Effects of isoflurane and isoflurane-nitrous oxide anesthesia on brain stem auditory evoked potentials in man. Anesth Analg 1984; 63: 245.
99. Artru AA, Lam AM, Johnson JO, Sperry RJ. Intracranial pressure, middle cerebral artery flow velocity, and plasma inorganic fluoride concentrations in neurosurgical patients receiving sevoflurane or isoflurane. Anesth Analg 1997; 85: 587-92.
100. Strebel S, Lam AM, Matta B, et al. Dynamic and static cerebral auto-regulation during isoflurane, desflurane, and propofol anesthesia. Anesthesiology 1995; 83: 66-76.
101. Talke P, Caldwell J, Dodsont B, Richardson CA. Desflurane and isoflurane increase lumbar cerebrospinal fluid pressure in normocapnic patients undergoing transphenoidal hypophysectomy. Anesthesiology 1996; 85: 999-1004.
102. Talke P, Caldwell JE, Richardson CA. Sevoflurane increases lumbar cerebrospinal fluid pressure in normocapnic patients undergoing transsphenoidal hypophysectomy. Anesthesiology 1999; 91:127-30.
103. Adams RW, Cucchiara RF, Gronert GA, et al. Isoflurane and cerebrospinal fluid pressure in neurosurgical patients. Anesthesiology 1981; 54: 97-9.
104. Muzzi DA, Losasso TJ, Dietz NM, et al. The effect of desflurane and isoflurane on cerebrospinal fluid pressure in humans with supratentorial mass lesions. Anesthesiology 1992; 76: 720-4.
105. Eger EI II. Isoflurane: a review. Anesthesiology 1981; 55: 559-76.
106. Fourcade HE, Stevens WC, Larson CP, et al. The ventilatory effects of Forane, a new inhaled anaesthetic. Anesthesiology 1971; 35: 26-31.
107. Knill RL, Kieraszewicz HT, Dodgson BG, Clement JL. Chemical regulation of ventilation during isoflurane sedation and anaesthesia in humans. Can Anesth SocJ 1983; 30: 607.
108. Rehder K, Mallow JE, Fibuch EE, et al. Effects of isoflurane anesthesia and muscle paralysis on respiratory mechanics in normal man. Anesthesiology 1974; 41: 477-85.
109. Carlsson AJ, Bindslev L, Hedenstierna G. Hypoxia-induced pulmonary vasoconstriction in the human lung. The effect of isoflurane anesthesia. Anesthesiology 1987; 66: 312-16.
110. Stevens WC, Cromwell TH, Halsey MJ, et al. The cardiovascular effects of a new inhalation anesthetic, Forane, in human volunteers at constant arterial carbon dioxide tension. Anesthesiology 1971; 35: 8-16.
111. Priebe HJ. Isoflurane causes more severe regional myocardial dysfunction than halothane in dogs with a critical coronary artery stenosis. Anesthesiology 1988; 69: 72-83.
112. Slogoff S, Keats A, Dear WE, et al. Steal prone coronary anatomy and myocardial ischemia associated with four primary anesthetic agents in humans. Anesth Analg 1991; 72: 22-7.
113. Leung JM, Hollenberg M, O'Kelly BF, et al. and the SPI Research Group. Effects of steal-prone anatomy on intraoperative myocardial ischemia. J Am Coll Cardiol 1992; 20: 1205-12.
114. Cason BA, Shubayev I, Hickey RF. Blockade of adenosine-triphosphate sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilatation. Anesthesiology 1994; 81:1245-55.
115. Kersten JR, Schmeling TJ, Hettrick DA, et al. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate potassium (KATP) channels. Anesthesiology 1996; 85: 794-807.
116. Holaday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981; 54: 100-6.
117. Brown B Jr. Sevoflurane: introduction and overview. Anesth Analg 1995; 81: S1-3.
118. Strum DP, Eger EI. Partition coefficients for sevoflurane in human blood, saline and olive oil. Anesth Analg 1987; 66: 654-6.
119. Malviya S, Lerman J. The blood/gas solubility of sevoflurane, isoflurane, halothane and serum constituent concentrations in neonates and adults. Anesthesiology 1990; 80: 814-24.
120. Nakajima R, Nakajima Y, Ikeda K. Minimum alveolar concentrations of sevoflurane in elderly patients. Br J Anaesth 1993; 70: 273-5.
121. Katoh T, Ikeda K. The minimum alveolar concentration (MAC) of sevoflurane in humans. Anesthesiology 1987; 66: 301-3.
122. Kimura T, Watanabe S, Asakura N, et al. Determination of end tidal sevoflurane concentration for tracheal intubation and minimum alveolar concentration in adults. Anesth Analg 1994; 79: 378-81.
123. Patel SS, Goa KL. Sevoflurane: a review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia. Drugs 1996; 51: 658-99.
124. Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane. Anesthesiology 1993; 79: 795-807.
125. Jiaxiang N, Sato N, Fojii K, Yuge O. Urinary excretion of hexafluoroisopro-panol glucuronide and fluoride in the urine in patients after sevoflurane anesthesia. J Pharm Pharmacol 1993; 45: 67-9.
126. Kameyama Y. Effect of isoflurane and sevoflurane on evoked potentials and EEG. Masui 1994; 43: 657-64.
127. Woodforth IJ, Hicks RG, Crawford MR, et al. Electroencephalographs evidence of seizure activity under deep sevoflurane anesthesia in a non-epileptic patient. Anesthesiology 1997; 87:1579-82.
128. Terasako K, Ishii S. Postoperative seizure-like activity following sevoflurane anesthesia. Acta Anaesthesiol Scand 1996; 40: 953-4.
129. Watts ADJ, Herrick IA, McLachlan RS, et al. The effect of sevoflurane and isoflurane anesthesia in interictal spike activity among patients with refractory epilepsy. Anesth Analg 1999; 89:1275-81.
130. Scheller MS, Nakakimura K, Fleischer JE, Zornow MH. Cerebral effects of sevoflurane in the dog: comparison with isoflurane and enflurane. Br J Anaesth 1990; 65: 388-92.
131. Kitaguchi K, Ohsumi H, Kuro M, et al. Effects of sevoflurane on cerebral circulation and metabolism in patients with ischemic cerebrovascular disease. Anesthesiology 1993; 79: 704-9.
132. Doi M, Ikeda K. Airway irritation produced by volatile anaesthetics during brief inhalation: comparison of halothane, enflurane, isoflurane and sevoflurane. Can J Anesth 1993; 40:122-6.
133. Doi M, Takahashi T, Ikeda K. Respiratory effects of sevoflurane used in combination with nitrous oxide and surgical stimulation. J Clin Anesth 1994; 6: 1-4.
134. Doi M, Ikeda K. Respiratory effects of sevoflurane. Anesth Analg 1987; 66: 241-4.
135. Ishibe Y, Gui X, Uno H, etal. Effect of sevoflurane on hypoxic pulmonary vasoconstriction in the perfused rabbit lung. Anesthesiology 1993; 79: 1348-53.
136. Shimizu T, Abe K, Kinouchi K, Yoshiya I. Arterial oxygenation during one lung ventilation. Can J Anesth 1997; 44:1162-6.
137. Mitsuhata H, Saitoh J, Shimizu R, et al. Sevoflurane and isoflurane protect against bronchospasm in dogs. Anesthesiology 1994; 81:1230-4.
138. Frink EJ, Malan TP Jr, Atlas M, et al. Clinical comparison of sevoflurane and isoflurane in healthy patients. Anesth Analg 1992; 74: 241-5.
139. Malan T, DiNardo J, Isner R, et al. Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers. Anesthesiology 1995; 83:918-28.
140. Hatakeyama N, Ito Y, Momose Y. Effects of sevoflurane, isoflurane and halothane on mechanical and electro-physiological properties of canine myocardium. Anesth Analg 1993; 76:1327-32.
141. Park WK, Pancrazio JJ, Suh CK, Lynch C. Myocardial depressant effects of sevoflurane. Mechanical and electrophysiologic actions in vitro. Anesthesiology 1996; 84:1166-76.
142. Ebert TJ, Muzi M, Lopatka CW. Neurocirculatory responses to sevoflurane in humans. A comparison to desflurane. Anesthesiology 1995; 83: 88-95.
143. Navarro R, Weiskopf R, Moore M, et al. Humans anesthetized with sevoflurane or isoflurane have similar arrhythmic response to epinephrine. Anesthesiology 1994; 80: 545-9.
144. Larach DR, Schuler HG. Direct vasodilatation by sevoflurane, isoflurane and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology 1991; 75: 268-78.
145. Kersten JR, Brayer AP, Pagel PS, et al. Perfusion of ischemic myocardium during anesthesia with sevoflurane. Anesthesiology 1994; 81: 995-1004.
146. Ebert TJ, Kharasch ED, Rooke GA, et al. Myocardial ischemia and adverse cardiac outcomes in cardiac patients undergoing non cardiac surgery with sevoflurane and isoflurane. Sevoflurane Ischemia Study Group. Anesth Analg 1997; 85: 993-9.
147. Yli-Hankala A, Randell T, Seppala T, Lindgren L. Increases in hemodynamic variables and catecholamine levels after rapid increase in isoflurane concentration. Anesthesiology 1993; 78: 266-71.
148. Moore MA, Weiskopf RB, Eger EI 2nd, et al. Rapid 1% increases of end-tidal desflurane concentration to greater than 5% transiently increases heart rate and blood pressure in humans. Anesthesiology 1994; 81: 94-8.
149. Takahata O, Ichihara K, Ogawa H. Effects of sevoflurane on ischaemic myocardium in dogs. Acta Anaesthesiol Scand 1995; 39: 449-56.
150. Izawa H, Takeda J, Fukushima K. The interaction between vecuronium and sevoflurane and its reversibility by neostigmine in man. Anesthesiology 1992; 77: A960.
151. Morita T, Tsukagoshi H, Sugaya T, et al. The effects of sevoflurane are similar to those of isoflurane on the neuromuscular block produced by vecuronium. Br J Anaesth 1994; 72: 465-7.
152. Kenna JG and Jones MJ. The organ toxicity of inhaled anesthetics. Anesth Analg 1995; 81: 551-66.
153. Wallin RF, Regan BM, Napoli M, Stern IJ. Sevoflurane: A new inhalational agent. Anesth Analg 1975; 54: 758-66.
154. Moriwaki G, Bito H, Ikeda K. Partly exhausted soda lime or soda lime with water added inhibits the increase in compound A concentration in the circle system during low flow sevoflurane anesthesia. Br J Anaesth 1997; 79: 782-6.
155. Bito H, Ikeuchi Y, Ikeda K. Effects of the water content of soda lime on compound A concentration in the anesthesia circuit in sevoflurane anesthesia. Anesthesiology 1998; 88: 66-71.
156. Ebert TJ, Messana LD, Uhrich TD, Staacke TS. Absence of renal and hepatic toxicity after 4 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesth Analg 1998; 86: 662-7.
157. Eger EI, Gong D, Koblin DD, et al. Dose related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 85:1154-63.
158. Eger EI, Koblin DD, Bowland T, et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 84:160-8.
159. Frink Jr EJ, Ghantous H, Malan TP. Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of renal and hepatic function. Anesth Analg 1992; 74: 231-5.
160. Eger EI. Partition coefficients of I-653 in human blood, saline, and olive oil. Anesth Analg 1987; 66: 971-3.
161. Rampil IJ, Lockhart SH, Zwass MS, et al. Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology 1991; 74: 429-33.
162. Taylor RH, Lerman J. Minimum alveolar concentration of desflurane and hemodynamic responses in neonates, infants and children. Anesthesiology 1991; 76: 975-9.
163. Patel SS, Goa KL. Desflurane: a review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia. Drugs 1995; 50: 742-67.
164. Koblin DD, Weiskopf RB, Holmes MA, et al. Metabolism of I-653 and isoflurane in swine. Anesth Analg 1989; 68:147-9.
165. Sutton TS, Koblin DD, Gruenke, et al. Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. Anesth Analg 1991;73:180-5.
166. Smiley RM, Ornstein E, Pantuck EJ, et al. Metabolism of desflurane and isoflurane to fluoride ion in surgical patients. Can J Anesth 1991; 38: 965-8.
167. Rampil IJ, Lockhart SH, Eger EI 2nd, et al. The electroencephalographic effects of desflurane in humans. Anesthesiology 1991; 74: 434-9.
168. Black S, Konstadt SN, Sami H, Rao TK. Effect of l-653(desflurane) on somatosensory evoked potentials. Anesthesiology 1990; 73: A181.
169. Newberg LA, Milde JH, Michelfelder JD. The cerebral metabolic effects of isoflurane at and above concentrations that suppress cortical electrical activity. Anesthesiology 1983; 59: 23-8.
170. Lutz LJ, Milde JH, Milde LN. The cerebral functional, metabolic and haemodynamic effects of desflurane in dogs. Anesthesiology 1990; 73: 125-31.
171. Zwass MS, Fisher DM, Welborn LG, et al. Induction and maintenance characteristics of anesthesia with desflurane and nitrous oxide in infants and children. Anesthesiology 1992; 76: 373-8.
172. Bunting HE, Kelly MC, Milligan KR. Effects of nebulized lignocaine on airway irritation and haemodynamic changes during induction of anesthesia with desflurane. Br J Anaesth 1995; 75: 631-3.
173. Lockhart SH, Rampil IJ, Yasuda N, et al. Depression of ventilation by desflurane in humans. Anesthesiology 1991; 74: 484-8.
174. Eger EI II. New inhaled anesthetics. Anesth Analg 1994; 80: 906-22.
175. Mazzeo AJ, Cheng EY, Stadnicka A, et al. Topographical differences in the direct effects of desflurane and halothane on canine airway smooth muscle. Anesth Analg 1994; 78: S274.
176. Park KW. Dai HB. Lowenstein E. Sellke FW. Epithelial dependence of the bronchodilatory effect of sevoflurane and desflurane in rat distal bronchi. Anesth Analg 1998; 86: 646-51.
177. Weiskopf RB, Cahalan MK, Eger EI 2nd, et al. Cardiovascular actions of desflurane in normocarbic volunteers. Anesth Analg 1991; 73:143-56.
178. Weiskopf RB, Cahalan MK, Ionescu P, etal. Cardiovascular actions of desflurane with and without nitrous oxide during spontaneous ventilation in humans. Anesth Analg 1991; 73:165-74.
179. Cahalan MK, Weiskopf RB, Eger EI, et al. Hemodynamic effects of desflurane/nitrous oxide anesthesia in volunteers. Anesth Analg 1991; 73: 143-56.
180. Merin RG, Bernard JM, Cohen M, Chelly JE. Comparison of the effects of isoflurane and desflurane on cardiovascular dynamics and regional blood flow in the chronically instrumented dog. Anesthesiology 1991; 74: 568-74.
181. Boban M, Stowe DF, Buljabasic N, et al. Direct comparative effects of isoflurane and desflurane in isolated guinea pig hearts. Anesthesiology 1992; 76: 775-80.
182. Hartmann JC, Pagel PS, Kampine JP, Warltier DC. Influence of desflurane on regional blood flow in a chronically instrumented canine model of multi vessel coronary artery obstruction. Anesth Analg 1991; 72: 289-99.
183. Helman JD, Leung JM, Bellows WH, et al., The SPI Research Group. The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. Anesthesiology 1992;77:47-62.
184. Ebert TJ, Muzi M. Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers. Anesthesiology 1993; 79: 444-53.
185. Weiskopf RB, Moore MA, Eger EI II, etal. Rapid increases in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans. Anesthesiology 1994; 80:1035-45.
186. Muzi M, Ebert TJ, Hope WG, Robinson BJ, Bell LB. Site(s) mediating sympathetic activation with desflurane. Anesthesiology 1996; 85:737-47
187. Weiskopf RB, Eger EI II, Noorani M, Daniel M. Fentanyl, esmolol and clonidine blunt the transient cardiovascular stimulation induced by desflurane in humans. Anesthesiology 1994; 81:1350-5.
188. Moore MA, Weiskopf RB, Eger EI, et al. Arrhythmogenic doses of epinephrine are similar during desflurane or sevoflurane anesthesia in humans. Anesthesiology 1993; 79: 943-7.
189. Rampil IJ, Zwass M, Lockhart SH, et al. Hemodynamics of I-653 in patients. Anesthesiology 1989; 71: A25.
190. Caldwell JE, Laster MJ, Magorian T, et al. The neuromuscular effects of desflurane, alone and combined with pancuronium or succinylcholine in humans. Anesthesiology 1991; 74: 412-18.
191. Kenna JG, Satoh H, Christ DD, Pohl LR. Metabolic basis for drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoracetyl group derive. J Pharmacol Exp Ther 1988; 245:1103-9.
192. Martin JL, Plevak DJ, Flannery KD, et al. Hepatotoxicity after desflurane anesthesia. Anesthesiology 1995 83:1125-9.
193. O'Keeffe NJ, Healy TEJ. The role of new anaesthetic agents. Pharmacol and Therapeutics 1999; 84: 233-48.
194. Korman B, Mapleson WW. Concentration and second gas effect: can the accepted explanation be improved? BrJAnaesth 1997; 78: 618-25.
195. Sakabe T, Kuramoto T, Kumagae S, TakeshitaH. Cerebral responses to the addition of nitrous oxide to halothane in man. Br J Anaesth 1976; 48: 957-62.
196. Jung R, Reinsel R, Marx W, et al. Isoflurane and nitrous oxide: comparative impact on cerebrospinal fluid pressure in patients with brain tumors. Anesth Analg 1992; 75: 724-8.
197. Moss E, McDowall DG. ICP increases with 50% nitrous oxide in oxygen in severe head injuries during controlled ventilation. Br J Anaesth 1979; 51:757-61.
198. Sebel PS, Flynn PJ, Ingram DA. Effect of nitrous oxide on visual, auditory and somatosensory evoked potentials. Br J Anaesth 1984; 56:1403-7.
199. Yacoub O, Doell D, Kryger MH, Anthonisen NR. Depression of hypoxic ventilatory response by nitrous oxide. Anesthesiology 1976; 45: 385-9.
200. Benumof JL, Wahrenbrock EA. Local effects of anesthetics on regional hypoxic pulmonary vasoconstriction. Anesthesiology 1975; 43: 525-32.
201. Eisle JH, Smith NT. Cardiovascular effects of 40 percent nitrous oxide in man. Anesth Analg 1972; 51:956-62.
202. Ebert TJ. Differential effects of nitrous oxide on baroreflex control of heart rate and peripheral sympathetic nerve activity in humans. Anesthesiology 1990; 72:16-22.
203. 12. Br J Anaesth 1987; 59: 3-13.
204. Cullen SC, Groaa EG. The anaesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951; 113: 580-2.
205. Dingley J, Ivanova-Stoilova TM, Grundler S, Walln T. Xenon: recent developments. Anaesthesia 1999; 54: 335-46.
206. Goto T, Saito H, Shinkai M, et al. Xenon provides faster emergence from anaesthesia than does nitrous oxide-sevoflurane or nitrous oxide-isoflu-rane. Anesthesiology 1997; 86:1273-8.
207. Ploughmann J, Astrup J, Pedersen J, Glydensted C. Effect of stable xenon inhalation on intracranial pressure during measurement of cerebral blood flow in head injury. J Neurosurg 1994; 81: 822-8.
208. Luttrop HH, Romner B, Perhag L, et al. Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. A transoesophageal echocardiography and transcranial Doppler study. Anaesthesia 1993; 48: 1045-9.
209. Calzia E, Stahl W, Handschuh T, et al. Respiratory mechanics during xenon anesthesia in pigs. Anesthesiology 1999; 91:1378-86.
210. Boomsma R, Ruprecht J, Man in't Veld AJ, et al. Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia 1990; 45: 273-8.
211. Franks NP, Lieb WR. Selective actions of volatile general anaesthetics at molecular and cellular level. Br J Anaesth 1993; 71: 65-76.
212. Sidebotham DA, Schug SA. Stereochemistry in anaesthesia. Clin Exp Pharm Phys 1997; 24:126-30.
213. Franks NP, Lieb WR. An anesthetic-sensitive super family of neurotrans-mitter-gated ion channels. J Soc Clin Anesth 1996; 8: 3S-7S.